PHERIN PHARMACEUTICALS
Drug Development | Pherin Pharmaceuticals
Pherin Pharmaceuticals is the leader in the development of first-in-class compounds called pherines, administered as a nasal spray in ultra-low-dose without the need for systemic exposure. Pherines have an excellent safety profile and rapid onset of efficacy demonstrated in clinical trials. We have a diverse product portfolio that increases the probability of commercial success and believes that the therapeutic advantages of our product candidates will result in purines becoming an important new class of approved pharmaceuticals.
